全文获取类型
收费全文 | 63461篇 |
免费 | 4680篇 |
国内免费 | 333篇 |
专业分类
耳鼻咽喉 | 643篇 |
儿科学 | 1606篇 |
妇产科学 | 1543篇 |
基础医学 | 7845篇 |
口腔科学 | 1537篇 |
临床医学 | 6384篇 |
内科学 | 14402篇 |
皮肤病学 | 809篇 |
神经病学 | 5013篇 |
特种医学 | 1928篇 |
外国民族医学 | 2篇 |
外科学 | 9860篇 |
综合类 | 1016篇 |
现状与发展 | 1篇 |
一般理论 | 103篇 |
预防医学 | 5254篇 |
眼科学 | 1850篇 |
药学 | 4442篇 |
中国医学 | 139篇 |
肿瘤学 | 4097篇 |
出版年
2023年 | 269篇 |
2022年 | 386篇 |
2021年 | 1155篇 |
2020年 | 729篇 |
2019年 | 1012篇 |
2018年 | 1246篇 |
2017年 | 849篇 |
2016年 | 975篇 |
2015年 | 1138篇 |
2014年 | 1779篇 |
2013年 | 2816篇 |
2012年 | 3782篇 |
2011年 | 4127篇 |
2010年 | 2349篇 |
2009年 | 2196篇 |
2008年 | 4016篇 |
2007年 | 4212篇 |
2006年 | 4041篇 |
2005年 | 4121篇 |
2004年 | 3848篇 |
2003年 | 3460篇 |
2002年 | 3429篇 |
2001年 | 741篇 |
2000年 | 634篇 |
1999年 | 724篇 |
1998年 | 741篇 |
1997年 | 611篇 |
1996年 | 494篇 |
1995年 | 493篇 |
1994年 | 466篇 |
1993年 | 442篇 |
1992年 | 544篇 |
1991年 | 521篇 |
1990年 | 422篇 |
1989年 | 443篇 |
1988年 | 402篇 |
1987年 | 378篇 |
1986年 | 360篇 |
1985年 | 426篇 |
1984年 | 439篇 |
1983年 | 397篇 |
1982年 | 533篇 |
1981年 | 448篇 |
1980年 | 493篇 |
1979年 | 308篇 |
1978年 | 333篇 |
1977年 | 330篇 |
1976年 | 272篇 |
1975年 | 296篇 |
1974年 | 254篇 |
排序方式: 共有10000条查询结果,搜索用时 125 毫秒
231.
99Tcm-HMPAO labelled leucocytes: comparison with 111In-tropolonate labelled granulocytes 总被引:1,自引:0,他引:1
A M Peters M E Roddie H J Danpure S Osman G P Zacharopoulos P George A W Stuttle J P Lavender 《Nuclear medicine communications》1988,9(6):449-463
The lipophilic complex, 99Tcm-hexamethylpropyleneamine oxime (HMPAO) is an efficient leucocyte label, and labels granulocytes with more stability than mononuclear leucocytes. The recovery of 99Tcm-HMPAO granulocytes, expressed as the percentage of injected granulocyte-associated activity circulating as granulocyte-associated activity 40-45 min after injection, was 37% (S.E. 3%), similar to the recovery of 111In-labelled granulocytes isolated and labelled in plasma using tropolone. The T1/2 of 99Tcm-HMPAO labelled granulocytes in blood was 4.4 h (S.E. 0.4 h), less than that of 111In-labelled granulocytes, although when a correction was made for 99Tcm elution, it was 6.4 h. The initial biodistribution of 99Tcm-labelled leucocytes was similar to 111In-labelled granulocytes, with a rapid initial lung transit, prominent splenic activity, bone marrow activity and minimal hepatic activity, although, unlike 111In, 99Tcm activity was also seen in urine, occasionally in the gallbladder, and, from about 4 h, consistently in the colon. Bone marrow activity was particularly prominent with 99Tcm. About 6% of 99Tcm was excreted in the faeces up to 48 h after injection, and about 17% in urine up to 24 h. The time-activity curves of reticuloendothelial activity up to 24 h were broadly similar for the two labelled cell preparations, and the differences that were observed can be explained on the basis of a higher rate of 99Tcm elution. Clinical information given by the two agents was similar in 27 of 30 patients who received both. Of the three who gave different information, one received 111In-labelled granulocytes which were considered to be functionally suboptimal and two, with inflammatory bowel disease, showed different distributions of abnormal bowel activity. We conclude that with respect to granulocyte kinetics and clinical data, 99Tcm-HMPAO labelled leucocytes are comparable with 111In-tropolonate labelled granulocytes. 相似文献
232.
233.
234.
Mark Warner George Eapen George W. Vetrovec 《Catheterization and cardiovascular interventions》1992,25(2):148-150
We describe a patient with two separate vessels having different origins supplying the circumflex coronary artery distribution. This represents a previously undescribed coronary artery anomaly. 相似文献
235.
E A George Z Salimi K Carney M Castaneda P J Garvin 《AJR. American journal of roentgenology》1988,150(4):811-816
To determine the value of scintigraphy to detect posttransplantation complications of the allografted pancreas, we retrospectively reviewed 209 scintigrams obtained with 99mTc-sulfur colloid (99mTc-SC) and 99mTc-glucoheptonate (99mTc-GH). The scintigraphic studies were performed in 37 recipients of simultaneous renal and pancreatic allografts harvested from the same donor. 99mTc-SC was used as an indicator of thrombotic vasculitis; pancreatic perfusion and blood-pool parameters were monitored with 99mTc-GH. In 11 of the 37 recipients, scintigraphic abnormalities suggested posttransplantation infarction. Recurrent episodes of acute rejection of the pancreatic allograft, which always coincided with acute rejection of the renal allograft, were monitored in 24 recipients. Rejection-induced ischemic pancreatitis was suggested in 12 of the 24 recipients and persisted in 10 recipients for several weeks after improvement of renal allograft rejection. Pancreatic atrophy was suggested scintigraphically in 16 of the 24 recipients with recurrent episodes of rejection. Spontaneous pancreatic-duct obstruction and obstructive pancreatitis were associated with a scintigraphic pattern similar to that of rejection-induced ischemic pancreatitis. We concluded that the specific radionuclides used in this series are useful for the surveillance and assessment of posttransplantation pancreatic infarction, acute rejection, pancreatitis, and atrophy. 相似文献
236.
237.
238.
585-nm Pulsed Dye Laser in the Treatment of Surgical Scars Starting on the Suture Removal Day 总被引:2,自引:0,他引:2
Keyvan Nouri MD Gloria P. Jimenez MD Catherine Harrison-Balestra BA George W. Elgart MD 《Dermatologic surgery》2003,29(1):65-73
BACKGROUND: The optimal time frame to improve the quality and cosmetic appearance of scars by laser therapy has not been clearly elucidated by prior controlled clinical trials. OBJECTIVE: To determine the efficacy of the 585-nm pulsed dye laser (PDL) in the treatment of surgical scars starting on the day of suture removal. METHODS: Eleven patients (skin types I-IV) with 12 postoperative linear scars that were greater than 2 cm were treated three times on monthly intervals with the 585-nm PDL (450 micro s, 10-mm spot size, 3.5 J/cm2 with 10% overlap) on one scar half, whereas the other half received no treatment. Scars were later evaluated by a blinded examiner using the Vancouver Scar Scale (VSS) for pigmentation, vascularity, pliability, and height. Scars were then blindly examined for cosmetic appearance using a visual analog scale. RESULTS: One month after the last treatment, final scar analysis by the blinded examiner revealed a significant difference between treated and untreated sites, with the treated halves scoring better in all scar parameters in the VSS and in cosmetic appearance. The treated halves demonstrated an overall average improvement in the VSS between the first treatment score and the final score of 54% versus 10% in the controls (P=0.0002). The cosmetic appearance score (0=worst; 10=best) at final assessment was significantly better for the treated scars, scoring 7.3 versus the averaged control score of 5.2 (P=0.016). CONCLUSION: The 585-nm PDL is effective and safe in improving the quality and cosmetic appearance of surgical scars in skin types I-IV starting on the day of suture removal. 相似文献
239.
240.
Lorraine V. Klerman Dr.P.H. Beth A. Baker M.S. George Howard Dr.P.H. 《The Journal of adolescent health》2003,32(6):452-455
This paper uses survival analysis to examine three large-scale, multi-site, randomized, controlled programs that attempted to prevent or delay second births to teenagers. Statistically significant differences in the hypothesized direction were found between the intervention and the control groups in the Elmira and Memphis Home Visitation sites. No statistically significant differences in the hypothesized direction were found in the Teen Parent Welfare Demonstration overall or in any of its three sites or in all New Chance sites combined. Delaying second pregnancies among teenagers requires intensive efforts. Survival analysis is a more accurate and useful way of presenting program results than simple analysis of the proportion of women with a second birth. 相似文献